Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Brian J Piper

Biographic Data

ID937211
NAMEBrian J Piper
GIVEN NAMESBrian J
FAMILY NAMEPiper
SIGNATUREPIPER B J
AFFILIATIONSGeisinger Commonwealth School of Medicine
ORCID0000-0002-2295-445X
VERIFIEDYes
TOTAL WORKS8
TOTAL CITATIONS0
AUTHOR COUNT8
EDITOR COUNT0
FIRST PUBLICATION YEAR2017
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States

    Open Access•Luke R Cavanah, Parita K Ray et al.•ARTICLE•Frontiers in Psychiatry•2025

    Despite limited evidence suggesting that citalopram and escitalopram have any meaningful differences in therapeutic or adverse effects, there exists a noticeable decline in the use of citalopram that cooccurred with an increase in escitalopram prescribing, consistent with our hypothesis. Moreover, among these general pharmacoepidemiologic trends exists significant geographic variability. There was disproportionate spending (relative to their use)…

  • National patterns of paroxetine use among US Medicare patients from 2015–2020

    Open Access•Luke R Cavanah, Jessica L Goldhirsh et al.•ARTICLE•Frontiers in Psychiatry•2024

    Despite the American Geriatrics Society's prohibition against paroxetine use in older adults and many effective treatment alternatives, paroxetine was still commonly used in the US in this population, especially in Kentucky and North Dakota and by neuropsychiatry and geriatric medicine. These findings provide information on the specialty types and states where education and policy reform would likely have the greatest impact on improving adherenc…

  • Substance use disorder risk assessment

    Open Access•Karen Arscott, Karen E Arscott et al.•ARTICLE•Frontiers in Psychiatry•2024

    This retrospective cross-sectional report shows the first affective responses to substances may predict risk for future SUD and could be a prevention screening tool. Asking patients about positive feelings with first usage of alcohol/opioids could be a simple screening tool employed for prevention

  • Pronounced Regional Variation in Esketamine and Ketamine Prescribing to US Medicaid Patients

    Alexia G Aguilar, Burke A Beauregard et al.•ARTICLE•Journal of Psychoactive Drugs•2023

    Ketamine and esketamine are efficacious for treatment-resistant depression. Unlike other antidepressants, ketamine lacks a therapeutic delay and decreases the risk for suicide. This cross-sectional study geographically characterized ketamine and esketamine prescribing to United States (US) Medicaid patients. Ketamine and esketamine prescription rates and spending per state were obtained. Between 2009 and 2020, ketamine prescribing rates peaked in…

  • Profiles of US Hispanics Unvaccinated for Covid-19

    Open Access•Brian J Piper, Bianca V Sanchez et al.•ARTICLE•Journal of Racial and Ethnic…•2022

  • Prescription Opioid Distribution after the Legalization of Recreational Marijuana in Colorado

    Open Access•Amalie K Kropp Lopez, Stephanie D Nichols et al.•ARTICLE•International Journal of…•2020

    There have been dynamic changes in prescription opioid use in the US but the state level policy factors contributing to these are incompletely understood. We examined the association between the legalization of recreational marijuana and prescription opioid distribution in Colorado. Utah and Maryland, two states that had not legalized recreational marijuana, were selected for comparison. Prescription data reported to the Drug Enforcement Administ…

  • Characteristics of Dispensary Patients that Limit Alcohol after Initiating Cannabis

    Assad Hayat, Brian J Piper•ARTICLE•Journal of Psychoactive Drugs•2019

    Many patients have reported that they decrease their use of opioids after starting medical cannabis (MC) but less is known for alcohol. The objective of this exploratory study was to identify any factors which differentiate alcohol abaters from those that do not modify their alcohol use after starting MC (non-abaters). Comparisons were made to identify any demographic, dosing, or health history characteristics which differentiated alcohol abaters…

  • Mother of Berries, ACDC, or Chocolope

    Brian J Piper•ARTICLE•Journal of Psychoactive Drugs•2017

    Medical marijuana patients often believe that specific strains are more efficacious at treating their conditions. The goals of this investigation were to determine: (1) how many strains of cannabis are there; (2) which strains are used by medical cannabis (MC) patients; and (3) are there any differences in the strains used by patient condition? Study I involved quantifying the number of strains listed in the online database leafly.com and categor…

No prominent works on this page.

  • Mother of Berries, ACDC, or Chocolope

    Brian J Piper•ARTICLE•Journal of Psychoactive Drugs•2017

    Medical marijuana patients often believe that specific strains are more efficacious at treating their conditions. The goals of this investigation were to determine: (1) how many strains of cannabis are there; (2) which strains are used by medical cannabis (MC) patients; and (3) are there any differences in the strains used by patient condition? Study I involved quantifying the number of strains listed in the online database leafly.com and categor…

  • Characteristics of Dispensary Patients that Limit Alcohol after Initiating Cannabis

    Assad Hayat, Brian J Piper•ARTICLE•Journal of Psychoactive Drugs•2019

    Many patients have reported that they decrease their use of opioids after starting medical cannabis (MC) but less is known for alcohol. The objective of this exploratory study was to identify any factors which differentiate alcohol abaters from those that do not modify their alcohol use after starting MC (non-abaters). Comparisons were made to identify any demographic, dosing, or health history characteristics which differentiated alcohol abaters…

  • Prescription Opioid Distribution after the Legalization of Recreational Marijuana in Colorado

    Open Access•Amalie K Kropp Lopez, Stephanie D Nichols et al.•ARTICLE•International Journal of…•2020

    There have been dynamic changes in prescription opioid use in the US but the state level policy factors contributing to these are incompletely understood. We examined the association between the legalization of recreational marijuana and prescription opioid distribution in Colorado. Utah and Maryland, two states that had not legalized recreational marijuana, were selected for comparison. Prescription data reported to the Drug Enforcement Administ…

  • Profiles of US Hispanics Unvaccinated for Covid-19

    Open Access•Brian J Piper, Bianca V Sanchez et al.•ARTICLE•Journal of Racial and Ethnic…•2022

  • Pronounced Regional Variation in Esketamine and Ketamine Prescribing to US Medicaid Patients

    Alexia G Aguilar, Burke A Beauregard et al.•ARTICLE•Journal of Psychoactive Drugs•2023

    Ketamine and esketamine are efficacious for treatment-resistant depression. Unlike other antidepressants, ketamine lacks a therapeutic delay and decreases the risk for suicide. This cross-sectional study geographically characterized ketamine and esketamine prescribing to United States (US) Medicaid patients. Ketamine and esketamine prescription rates and spending per state were obtained. Between 2009 and 2020, ketamine prescribing rates peaked in…

  • National patterns of paroxetine use among US Medicare patients from 2015–2020

    Open Access•Luke R Cavanah, Jessica L Goldhirsh et al.•ARTICLE•Frontiers in Psychiatry•2024

    Despite the American Geriatrics Society's prohibition against paroxetine use in older adults and many effective treatment alternatives, paroxetine was still commonly used in the US in this population, especially in Kentucky and North Dakota and by neuropsychiatry and geriatric medicine. These findings provide information on the specialty types and states where education and policy reform would likely have the greatest impact on improving adherenc…

  • Substance use disorder risk assessment

    Open Access•Karen Arscott, Karen E Arscott et al.•ARTICLE•Frontiers in Psychiatry•2024

    This retrospective cross-sectional report shows the first affective responses to substances may predict risk for future SUD and could be a prevention screening tool. Asking patients about positive feelings with first usage of alcohol/opioids could be a simple screening tool employed for prevention

  • Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States

    Open Access•Luke R Cavanah, Parita K Ray et al.•ARTICLE•Frontiers in Psychiatry•2025

    Despite limited evidence suggesting that citalopram and escitalopram have any meaningful differences in therapeutic or adverse effects, there exists a noticeable decline in the use of citalopram that cooccurred with an increase in escitalopram prescribing, consistent with our hypothesis. Moreover, among these general pharmacoepidemiologic trends exists significant geographic variability. There was disproportionate spending (relative to their use)…

Medicine (8 works) · Internal Medicine (5 works) · Psychiatry (5 works) · Medical prescription (4 works) · Cannabis and Cannabinoid Research (3 works) · Family medicine (3 works) · Pharmacology (3 works) · Addiction (2 works) · Alcohol (2 works) · Alcohol use disorder (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae